Suppr超能文献

基因编码 PBP3 和 PBP4 的移码突变导致. 出现一种不寻常的、极端的β-内酰胺耐药表型

Frameshift Mutations in Genes Encoding PBP3 and PBP4 Trigger an Unusual, Extreme β-Lactam Resistance Phenotype in .

机构信息

Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, Ohio 44106, United States.

Research Service, Veterans Affairs Northeast Ohio Healthcare System, Cleveland, Ohio 44106, United States.

出版信息

ACS Infect Dis. 2024 Nov 8;10(11):3810-3820. doi: 10.1021/acsinfecdis.4c00330. Epub 2024 Oct 23.

Abstract

In our curated panel of complex isolates, strain AU28442 was unusually highly β-lactam resistant. To explore the molecular mechanisms leading to this phenotype, we performed whole genome sequencing (WGS) and microbiological and biochemical assays. WGS analysis revealed that strain AU28442 produced two β-lactamases, AmpC22 and a novel PenA-like β-lactamase denominated PenA39. Additionally, the strain presented frame-shift mutations in the genes encoding penicillin binding proteins 3 (PBP3) and 4 (PBP4). The antibiotic susceptibilities of the parent AU28442 strain carrying vs the isogenic strain producing were discrepant with ceftazidime MICs of >512 and 1 μg/mL, respectively. Accordingly, PenA39 was found to poorly hydrolyze β-lactams with values of ≤8.8 s. An overlay of the crystal structure of PenA39 with PenA1 revealed a shift in the SDN loop in the variant, which may affect the catalytic efficiency of PenA39 toward substrates and inhibitors. Moreover, microscopic examination of AU28442 revealed shortened rod-shaped cells compared to ATCC 17616, which carries a full complement of intact PBPs. Further complementation assays confirmed that the loss of PBP3 and PBP4 was the main factor contributing to the high-level β-lactam resistance observed in AU28442. This information allowed us to revert susceptibility by pairing a potent β-lactamase inhibitor with a β-lactam with promiscuous PBP binding. This detailed characterization of provides an illustration of the myriad ways in which bacteria under antibiotic selection can develop resistance and demonstrates a mechanism to overcome it.

摘要

在我们精心挑选的复杂分离株中,菌株 AU28442 对β-内酰胺类药物的耐药性异常高。为了探索导致这种表型的分子机制,我们进行了全基因组测序(WGS)和微生物学及生化分析。WGS 分析显示,菌株 AU28442 产生了两种β-内酰胺酶,即 AmpC22 和一种新型的 PenA 样β-内酰胺酶,命名为 PenA39。此外,该菌株在编码青霉素结合蛋白 3(PBP3)和 4(PBP4)的基因中存在移码突变。携带 和 的亲本 AU28442 菌株和同源性产生菌株的药敏试验结果不一致,头孢他啶 MIC 值分别为 >512 和 1 μg/mL。因此,PenA39 对β-内酰胺类药物的水解能力较差, 值 ≤8.8 s。PenA39 的晶体结构与 PenA1 的叠加显示,变体中的 SDN 环发生了位移,这可能影响 PenA39 对底物和抑制剂的催化效率。此外,与 ATCC 17616 相比,AU28442 的显微镜检查显示出较短的杆状细胞,后者携带完整的完整 PBPs。进一步的互补试验证实,PBP3 和 PBP4 的缺失是导致 AU28442 观察到高水平β-内酰胺类药物耐药的主要因素。这些信息使我们能够通过将一种有效的β-内酰胺酶抑制剂与一种具有广谱 PBPs 结合的β-内酰胺类药物配对来恢复敏感性。对提供了一个说明,说明了在抗生素选择下,细菌可以通过多种方式产生耐药性,并展示了克服耐药性的一种机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验